Axxcess Wealth Management LLC Acquires 17,569 Shares of Haleon plc (NYSE:HLN)

Axxcess Wealth Management LLC boosted its holdings in Haleon plc (NYSE:HLN) by 39.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 62,393 shares of the company’s stock after acquiring an additional 17,569 shares during the period. Axxcess Wealth Management LLC’s holdings in Haleon were worth $515,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in HLN. Janney Montgomery Scott LLC increased its position in Haleon by 182.3% during the 1st quarter. Janney Montgomery Scott LLC now owns 438,833 shares of the company’s stock worth $3,726,000 after buying an additional 283,410 shares during the period. Capstone Investment Advisors LLC bought a new position in Haleon during the 1st quarter worth $1,969,000. Wellington Management Group LLP increased its position in Haleon by 164.6% during the 4th quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after buying an additional 8,423,475 shares during the period. Douglas Lane & Associates LLC increased its position in Haleon by 2.1% during the 1st quarter. Douglas Lane & Associates LLC now owns 8,401,876 shares of the company’s stock worth $71,332,000 after buying an additional 175,082 shares during the period. Finally, Procyon Advisors LLC increased its position in Haleon by 559.9% during the 1st quarter. Procyon Advisors LLC now owns 131,665 shares of the company’s stock worth $1,118,000 after buying an additional 111,713 shares during the period. Institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on HLN shares. Berenberg Bank started coverage on Haleon in a research report on Tuesday, August 6th. They set a “buy” rating on the stock. Morgan Stanley increased their price objective on Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a research report on Friday. Finally, The Goldman Sachs Group lowered Haleon from a “buy” rating to a “neutral” rating in a report on Tuesday, August 6th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Stock Performance

HLN opened at $10.52 on Friday. The firm has a market cap of $48.04 billion, a P/E ratio of 35.07, a price-to-earnings-growth ratio of 3.10 and a beta of 0.26. Haleon plc has a 52-week low of $7.70 and a 52-week high of $10.76. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The business’s fifty day moving average is $9.76 and its 200-day moving average is $8.87.

Haleon (NYSE:HLN) last released its earnings results on Thursday, August 1st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). The company had revenue of $3.50 billion for the quarter, compared to analyst estimates of $3.55 billion. Haleon had a return on equity of 13.15% and a net margin of 9.71%. During the same period last year, the company posted $0.08 earnings per share. Sell-side analysts expect that Haleon plc will post 0.46 EPS for the current fiscal year.

Haleon Cuts Dividend

The firm also recently disclosed a semi-annual dividend, which was paid on Thursday, September 19th. Investors of record on Friday, August 16th were paid a $0.0514 dividend. This represents a yield of 1.6%. The ex-dividend date was Friday, August 16th. Haleon’s dividend payout ratio (DPR) is presently 33.33%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.